Numinus Wellness Inc · OTC:NUMIF
Numinus Wellness — Merger or Acquisition (April 2022)
15 slides from Numinus Wellness's merger presentation, Apr 11, 2022
Slide 1: Creating a leading, integrated mental healthcare company providing psychedelic-assisted therapies
Creating a leading, integrated mental healthcare company providing psychedelic-assisted therapies April 11, 2022 April 11, 2022
Slide 2: Forward-looking statements
This presentation includes certain “forward‐looking information” and “forward‐looking statements” (collectively “forward‐looking statements”) within the meaning of applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs and current expectations of th
Slide 3: Key Acquisition Benefits
Key Acquisition Benefits Rapidly expands Numinus’ operations and brand in the U.S. with a reputable platform of revenue producing clinics with an established and growing client base. Grows client programming as complementary service offerings will be shared and expanded across the combined clinic ne
Slide 4: Combined Revenue Growth and Pro-forma Combined Revenue
Combined Revenue Growth Pro-forma Combined Revenue (Trailing 4 quarters) (Trailing 4 quarters) Novamind Numinus C$3.2 mil C$9.98 mil C$2.3 mil C$2.3 mil C$2.1 mil C$7.9 mil C$2.1 mil Q2Q2 2021 / Q3 2021/ Q3 2021 / Q4 Q3 2021/ Q4Q4 2021 / Q1 2021/ Q1Q1 2022 / Q2 2021/ Q32021 2021 2021 Q4 2021 Q12022
Slide 5: Numinus Clinic Growth and Number of Practitioners
Number of Practitioners Numinus Clinic growth Wellness clinics Clinical research sites 120 111 20 18 17 100 16 14 4 80 66¹ 12 10 13 60 10 45 7 7 8 40 6 4 4 4 20 4 1 2 0 0 Numinus Novamind Combined ¹A large component of Numinus’ current therapy services are delivered virtually, outside of clinics. 5
Slide 6: Numinus to acquire all issued and outstanding shares of Novamind Inc.
• Numinus to acquire all the issued and outstanding shares of Novamind Inc. (the “Transaction”) by way of a court approved Plan of Arrangement (the “Arrangement”) • Novamind shareholders will receive 0.84x of a Numinus common share in exchange for each Novamind share held • Implies a transaction val
Slide 7: Numinus wellness clinics and research lab
A network of wellness clinics providing a wide range of Numinus’ research lab is actively developing IP, advancing mental health services, including psychedelic and non- research and generating revenue through contract research psychedelic services for comprehensive, integrated and industry innovati
Slide 8: $380 Billion+ total addressable market for mental health
Current systems are not equipped to handle skyrocketing global rates of mental illness, addiction and trauma, further exacerbated by The global mental health market is the pandemic. estimated to reach $537.97 billion by 2030, growing at a CAGR of 3.5% from 2021 to 2030.¹ Approximately 1 in 11 people
Slide 9: Expansion of services across combined platform
Depression, Anxiety. Bipolar disorder, Substance use disorder, ADHD, OCD, PTSD, Eating disorders, Suicidal ideation • Group traditional therapy • Traditional therapy • Virtual psychotherapy • Ketamine-assisted therapies • KAP Pod program • Mindfulness programs • TMS • Psychedelic-assisted therapies
Slide 10: Combined clinic and research network
NUMINUS: (Canada) 5 wellness clinics 2 research clinics 1 research lab NOVAMIND: (US) 8 wellness clinics 2 research clinics COMBINED: 13 client wellness clinics 4 research clinics 1 research lab 10
Slide 11: Research lab and clinical research site synergies
• Bioanalysis & Invitro Studies • Recruitment of study participants via research sites co- • Product Development & R&D located with psychiatry clinics • Extraction technologies • Development of psychedelic therapy protocols and • Research small batch manufacturing programs for difficult to treat men
Slide 12: Transaction timeline
April 11, May May June Summer 2022 2022 Information about Novamind Numinus Following The integration of the proposed shareholders will shareholders will shareholder and Novamind operations transaction made receive voting receive voting regulatory onto Numinus’ available. information in information i
Slide 13: Pro forma capitalization and transaction valuation
Share Price as of (April 8, 2022) (C$/sh) $0.53 NUMI Common Shares Outstanding (mm) 208 (+) Shares Issuable to Novamind Shareholders (mm) 50 (+) ITM Dilutives (mm) 16 Fully Diluted Shares Outstanding (mm) 273 (C$mm) $145 (+) Debt (C$mm) $0 (-) Cash (C$mm) $57 (C$mm) $88.3 13
Slide 14: Strategic rationale summary
Numinus’ initial Positions Numinus as Grows client service Combines Novamind’s Accelerates expansion into the a leading provider of offering as leading clinical research Numinus’ path to U.S. market with a integrative mental complementary site management profitability through leading clinic health c
Slide 15: Contact
Email: invest@numinus.com IR website: investors.numinus.com
Numinus Wellness — Merger or Acquisition (April 2022) on 6ix